US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 18, 2016 (10 years ago)

Milrinone 200 mcg/mL in a) D5W-300 mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Sterility Assurance

What was recalled

Milrinone 200 mcg/mL in a) D5W-300 mL, b) D5W-400 mL, c) D5W-500 mL and d) D5W-600 mL Bags, FOR IV USE ONLY, Baptist Health Medical Towers Pharmacy & Infusion, Little Rock, AR

Recalling firm
Baptist Health Medical Towers Pharmacy and Infusion Services
Origin
AR, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0930-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Milrinone recalls

See all
Class III · Low risk Terminated

Milrinone Lactate Injection

Reason Failed Impurities/Degradation Specifications

Caplin Steriles Limited NDC 72485-502-01 D-1144-2023
Class II · Moderate risk Terminated

Milrinone

Reason Lack of sterility assurance

Sentara Infusion Services D-0307-2023
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-23 D-1487-2019
Class II · Moderate risk Terminated

Milrinone Lactate Injection 200 mcg

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Pfizer Inc. NDC 0409-2776-02 D-1486-2019
Class II · Moderate risk Terminated

Milrinone Lactate in 5% Dextrose Injection

Reason Lack of assurance of sterility: customer complaints received for the presence of leaks.

Baxter Healthcare Corporation NDC 0338-6010-48 D-0789-2017